CREB1 and viral infectious disease: Next, we treated the LV-CREB133-GFP-infected mice with 8-OH-DPAT (i.p., 0.1 mg/kg/d, × 21 d) and the LV-VP16-CREB-GFP-infected mice with NAN-190 (i.p., 0.3 mg/kg/d, × 21 d) starting at d 7 after virus infection.